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Factors Influencing Breast Cancer Genetic Testing Among High Risk African
American Women: A Systematic Review
Abstract
African American women are disproportionately impacted by breast cancer and its associated effects.
They have the highest breast cancer mortality rate of all racial and ethnic groups in the U.S., yet, many
high risk African American women do not follow-up with genetic testing despite, having a shorter survival
rate and more likely to develop malignancies or aggressive forms of breast cancer than white women.
Purpose
Purpose: This review explored breast cancer genetic follow up and barriers among African American
women and made recommendations for designing tailored high risk breast cancer programs. Method:
The Integrative Model of Behavioral Prediction framework provided the framework for the review. PubMed,
PSYINFO, CINAHL and Cochrane Collection Plus databases were searched for articles published from
2007 to 2017 that focused on attitude and beliefs that influenced genetic testing follow up among African
American women. Three reviewers independently reviewed and appraised articles. The quality of the
articles was assessed to determine the evidence level and overall recommendations using the Joanna
Bridge Institute grading criteria. Results: Sixteen of the 2275 articles reviewed met the inclusion criteria
of which, seven showed statistically significance changes related to family concerns, medical mistrust
and cost barriers; decreases in breast cancer worry and perceived risk after genetic counseling; and
higher education level and diagnosed early increased genetic testing. Conclusions
Conclusions: This systematic review
provides greater understanding of how the social determinants of health influence decisions about genetic
testing and treatment to determine why African American women who are at risk for breast cancer, do not
progress to genetic testing. It provided recommendations for designing sensitive curriculum content for
African American women and providers to increase genetic follow-up and reduce breast cancer disparity.
The results of this review could be used to design comprehensive, tailored interventions to address
the identified barriers, increase breast cancer awareness and early detection, and help minority women
make informed, value decisions about genetic testing and treatment options. Recommendations: Future
research is required to examine the role communities, agencies and policy makers play in improving clinical
outcomes for minorities.
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ABSTRACT
Background: African American women are disproportionately impacted by breast cancer and its associated effects. They have
the highest breast cancer mortality rate of all racial and ethnic groups in the U.S., yet, many high risk African American women do
not follow-up with genetic testing despite having a shorter survival rate and being more likely to develop malignancies or aggressive
forms of breast cancer than White women. Purpose: This review explored breast cancer genetic follow up and barriers among
African American women and made recommendations for designing tailored high risk breast cancer programs. Method: The
Integrative Model of Behavioral Prediction framework provided the framework for the review. PubMed, PSYINFO, CINAHL and
Cochrane Collection Plus databases were searched for articles published from 2007 to 2017 that focused on attitude and beliefs
that influenced genetic testing follow up among African American women. Three reviewers independently reviewed and appraised
articles. The quality of the articles was assessed to determine the evidence level and overall recommendations using the Joanna
Briggs Institute grading criteria. Results: Sixteen of the 2275 articles reviewed met the inclusion criteria, of which seven showed
statistically significant changes related to family concerns, medical mistrust, and cost barriers; decreases in breast cancer worry
and perceived risk after genetic counseling; and higher education level and diagnosed early increased genetic testing.
Conclusions: This systematic review provides greater understanding of how the social determinants of health influence decisions
about genetic testing and treatment to determine why African American women who are at risk for breast cancer do not progress
to genetic testing. It provided recommendations for designing sensitive curriculum content for African American women and
providers to increase genetic follow-up and reduce breast cancer disparity. The results of this review could be used to design
comprehensive, tailored interventions to address the identified barriers, increase breast cancer awareness and early detection,
and help minority women make informed, value decisions about genetic testing and treatment options. Recommendations: Future
research is required to examine the role communities, agencies, and policy makers play in improving clinical outcomes for
minorities.
Keywords: breast cancer, genetic test, African American women, barriers, attitude/beliefs, social determinants of health

© The Internet Journal of Allied Health Sciences and Practice, 2019

FACTORS INFLUENCING BREAST CANCER GENETIC TESTING AMONG AFRICAN AMERICAN WOMEN

1

INTRODUCTION
In the United States, breast cancer is the most common cancer among women of all races/ethnicities and the second leading
cause of cancer deaths.1 Although more White women (WW) are diagnosed with breast cancer, African American women (AAW)
are disproportionately impacted by breast cancer and its associated effects. They have the highest breast cancer mortality rate of
all racial and ethnic groups, have a higher occurrence of breast cancer before age 50, are diagnosed later, have a shorter survival
rate, are affected by earlier-onset and aggressive, are difficult to treat triple-negative breast cancer (TNBC), and are more likely to
have malignant genetic variants than WW.2-4
Early detection and prompt treatment have been demonstrated to reduce breast cancer mortality and extend or improve quality of
life.5 However, many AAW with breast cancer miss opportunities for early interventions. Underutilization and irregular utilization of
breast cancer screening among AAW may contribute to the disparities in survival and mortality rates.6,7 This reduced adherence
to breast cancer screening guidelines leads to later stage cancer diagnoses in AAW, a factor correlated with lower survival rates.8,9
Even a three-month treatment delay can contribute to breast cancer mortality.10 One study reported only 64% of AAW aged 40
years and over adhere to recommendations for annual clinical breast examination; even fewer (50%) reported adhering to the most
effective early detection, risk reducing, and clinical management strategies.5
An estimated 5%–10% of breast cancers are hereditary, and primarily attributed to BRCA1 or BRCA2 gene mutations.1 Although
the population of AAW who have these gene mutations is low, risk assessment through genetic counseling and testing is vital. It
provides the opportunity to gain early access to preventative and specialized care and provides them with information to make
valued informed health care decisions. Women with a personal history of breast cancer have a 55%-85% lifetime risk. Women
with BRCA1 or BRCA2 mutation have a distinctly increased risk for the disease, especially for women age 40 and younger.11,12
Furthermore, women with a BRCA1 mutation have a lifetime risk as low as 31%.2,13 The prevalence of the disease increases as
the mutated gene is passed on to their children.
Social Determinants of Health (SDOH)
The SDOH-economic stability, health literacy/education, social and community context, healthcare system, and neighborhood and
built environments play a key role in the uptake of genetic testing.6,14 Approximately 85% of all breast cancer is nonhereditary and
associated with the SDOH.2,3,15 Although there is a critical need to conduct more genetic testing among AAW diagnosed with
breast cancer, evidence suggests that many high-risk AAW do not follow-up with testing because of barriers related to the SDOH.16
Barriers such as limited health literacy and psychological distress associated with inability to understand genetic information,
access to healthcare services, ineffective communication, attitude and cultural beliefs, family, and socioeconomic status may
explain why AAW are hesitant to follow-up.5 One study suggests that AAW with breast cancer are 78% less likely to undergo
genetic screening and testing as compared to WW with comparable histories because of socioeconomic factors, risk perception,
attitudes, or primary care physician recommendations.17
Although numerous studies support the benefits of genetic screening and testing for breast cancer genetic variants, little is known
about AAW’s attitudes or recent experiences with genetic testing, why many do not progress to testing, or why interventions to
increase genetic testing have been implemented, but with little progress.1,10 The aim of this systematic review is to synthesize
current evidence exploring breast cancer genetic testing follow up and barriers from the perspective of AAW and make
recommendations to consider when designing tailored high-risk breast cancer programs.
Theoretical Framework
The Integrative Model of Behavioral Prediction (IMBP) framework provided the framework for the review. This model postulates
that intentions are the strongest predictor of behavior, and individuals will act on them when they have the essential skills and
environmental constraints do not impede behavioral performance.18 The intentions are formed by the interactions of perceived
social norm, attitude and self-efficacy. The association between background factors and behavior depicts the flexibility and
adaptability of the model to varied cultures, contexts, and diverse populations.
According to the IMBP, the intention to pursue genetic screening and testing can be influenced by attitudes, beliefs about social
norms, and control beliefs (self-efficacy). Also, the IMBP evaluates the effects of barriers that may influence an individual’s decision
to progress to genetic screening and testing. The model provides opportunities for tailored educational intervention to help women
diagnosed with breast cancer understand genetic screening and testing, improve the accuracy of risk perception, and address
psychosocial aspects and information to facilitate informed health care decisions.
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METHODS
The systematic approach, consisting of input-searching the literature, throughput- processing the literature, and output– writing the
review was employed. A combination of quantitative and qualitative reviews is included to develop a deeper understanding of the
socio-psychological and experiential phenomenon of why AAW diagnosed with breast cancer do not follow-up with genetic testing.
Search Strategy
The search was conducted using PubMed, CINAHL, PSYINFO, and Cochrane Collection Plus strategies using a combination of
the following subject headings and keywords: “breast cancer barriers” AND “genetic testing,” “breast cancer genetic testing AND
“AAW barriers,” and “breast cancer genetic testing” AND “African Americans’ attitudes.” The search was limited to English
language articles from 2007 to 2017. Studies published prior to the year 2007 were excluded because they were not reflective of
the existing breast mortality and survival rates, advanced treatments, and progress. The search was designed to retrieve various
subtopics within the main topic, including beliefs and perceptions.
Study Selection
Three authors conducted the search, coded the studies, and independently reviewed the coded studies. Disagreements among
the coders and the reviewers were discussed until agreement was reached among all authors. We conducted a three-stage
screening process beginning with a title review, abstract review, and full text article review to determine eligibility.
Data Abstraction and Tabulation
Articles details were abstracted using data abstraction forms to collect data and create reports on the year of publication, study
design, sample size, population, focus, measures, grading quality, and recommendations.
Quality Assessment and Grading
The process of the grading of evidence is depicted in Table 1. The validity of the articles selected for the review was assessed
using a modified Joanna Briggs Institute (JBI) grading of evidence level for effectiveness and meaning.19 Quantitative studies were
assessed and rated according to five levels of effectiveness, and qualitative studies were rated according to five levels of
meaningfulness. Quantitative studies were assessed and rated according to five levels of effectiveness, with level one experimental design, representing the strongest evidence and level 5-expert opinion and bench research, representing the weakest
evidence. Qualitative studies were rated according to five levels of meaningfulness, with level 1-qualitative or mixed methods
systematic reviews and level 5-expert opinion, representing the least meaningfulness
Table 1. JBI Level of Evidence Scales for Effectiveness and Meaningfulness
Levels of Evidence
Effectiveness
Level 1: Experimental design
Levels 2: Quasi-experimental design,
Levels 3: Observational,-analytic design
Levels 4: Observational,-descriptive design
Levels 5: Expert opinion and bench research
Meaningfulness
Level 1: Qualitative or mixed methods systematic reviews
Level 2: Qualitative or mixed methods synthesis
Level 3: Single qualitative study
Level 4 Systematic review of expert opinion
Level 5: Expert opinion
Adapted with permission The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation.19
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The JBI Grades of Recommendations were used to integrate the best available evidence on breast cancer genetic test follow up
and barriers from the perspective of AAW and make evidence-based recommendations for designing tailored risk breast cancer
programs (See Table 2). The JBI has two grades for recommendations: Grade A is a strong recommendation and Grade B is a
weak recommendation.19 All studies are evaluated using the FAME (feasibility, appropriateness, meaningfulness, and
effectiveness) scale developed by the JBI.19

Table 2. Grades of Recommendation
Grade

Definition

A

‘Strong’ recommendation. (1) Desirable effects outweigh undesirable effects of the health management strategy;
(2) evidence of adequate quality supporting its use; (3) there is a benefit or no impact on resource use, and (4)
values, preferences and the patient experience have been taken into account.

B

‘Weak’ recommendation (1) desirable effects appear to outweigh undesirable effects of the health management
strategy, though not clear; (2) evidence supporting its use, even though this may not be of high quality; (3) there
is a benefit, no or minimal impact on resource use, and (4) values, preferences and the patient experience may or
may not have been taken into account.

Adapted with permission The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation. 19

RESULTS
Search Results
The search identified 2275 distinctive articles. The title and abstract screens were retained. Of these, 86 articles were selected for
further consideration, and 2163 articles were removed after accounting for duplication or did not include breast cancer genetic test
or classify race/ethnicity. Of the remaining 30 articles, 14 articles did not include barriers to breast cancer genetic test, African
American beliefs, attitudes, or perceptions or meet the African American 10% minimum sampling requirement. Full text screening
with reference list searching identified 16 articles that met the target criteria. The article selection process is depicted in Figure 1.
Articles included in the review met the study inclusion and exclusion criteria (See Table 3).
Table 3. Study Inclusion and Exclusion Criteria
Inclusion Criteria

Exclusion Criteria

1. Studies in English

1. Studies not in English

2. Peer reviewed studies

2. Studies more than 10 years old

3. Studies published from 2007-2017

3. Studies not in the United States

4. Studies included African American women

4. Race/ethnicity is not classified

5.African American women represented at least 10% of
sample

5. African American women participants were < 10% of
sample

6. Examined or explored attitudes, perceptions, beliefs or
barriers related to genetic testing

6. Contained commentaries or discussions on the subject
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Figure 1. PRISMA flowchart of eligible studies20

Characteristics of the Study Samples
Characteristics identified and summary of review are presented in Table 4 (see Appendix A). Sixteen quantitative and qualitative
studies comprised this review. Twenty-five percent of the studies collected data using qualitative designs, 25% used cross
sectional designs, 12% used secondary analysis, 6% used randomized trial design, 6% used retrospective design, 6% used
systematic review design, 6% used integrative review design, 6% used prospective analysis design, and 6% used a descriptive
design. Of these studies, eleven studies included samples comprised of AAW, two included 18% or less AAW, one study included
24%, one study included 26%, and another included 65%. Ten studies included all adults, one study classified the sample as
below age 50, one study classified the sample as age 20-69, one study classified the sample as mean age 52, one study classified
the sample as age 25-49, one study classified the sample as age 20-45, and one study classified the sample as age 21 and older.
The most common outcomes in the studies reviewed were breast cancer-related beliefs, attitudes and perceptions (psychosocial,),
knowledge and perceived risk (cognitive), and health care system.
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Beliefs, Attitudes, and Perceptions (psychosocial factors)
Most of the women reported interest in genetic testing and associated breast cancer-related beliefs, attitudes, or perceptions with
knowledge and perceived risk as primary outcomes. Benefits to genetic screening and testing included providing education to
raise breast cancer awareness, information to prevent breast cancer, and information to make informed decisions (18%). Two out
of sixteen articles (12%) cited physician recommendation as motivators to progress to genetic testing. The four studies that
assessed religion and spirituality reported a possible association with coping, hope, and genetic follow up.
Knowledge and Perceived Risk (cognitive)
Lack of knowledge of breast cancer and risk factors were negatively associated with genetic testing follow up. Half of the studies
reported low and inaccurate breast cancer knowledge among AAW. One study suggested that minority women have low levels of
genetic testing awareness, and this influenced their decision to progress to genetic counseling/genetic testing. Another study
explored misunderstanding about genetic tests. Most participants lacked knowledge about genetic tests and believed the tests
are more predictive than they actually are. Only one study reported no clear association between feeling susceptible to getting
breast cancer and the likelihood of being in a group that received or did not receive breast cancer genetic counseling.
Barriers
A summary of barriers is presented in Table 5. All studies assessed the healthcare system and reported barriers to genetic testing
follow up and treatment. Barriers identified from the review are classified according to the SDOH. These barriers experienced by
AAW were associated with economic stability, education, social and community context, the health care system, and neighborhood
and built environments. The economic stability determinant focused on employment and income including constraints beyond the
individual’s ability to pay for services and work conflict. Education focused on health literacy and education level including lack of
knowledge about genetic counseling/testing, perceived risk, testing process/procedures/effects, risk management, and results.
These factors limited individuals’ ability to make informed health care and treatment decisions. The most common barriers in the
studies reviewed were related to social and community context (psychosocial), health care system, and education (cognitive),
respectively.
Social and Community Context (psychosocial,)
The influence of social factors on an individual’s belief or behavior were the most commonly cited barriers. Fourteen out of sixteen
(87%) of the articles cited social barriers. Family concerns (50%) followed by fear or worry of positive breast cancer results (43%),
discrimination related to employment, healthcare system or denied health coverage due to pre-existing conditions (37%), medical
mistrust (31%), and stigmatization due to breast cancer status (31%) were the most common social barriers. Other barriers
included lack of privacy (18%), shame of being a burden to society (12%), fatalism, powerless to control the onset and progression
of cancer (12%), nonscientific beliefs (6%), and disinterest (6%).
Healthcare System
The healthcare system barriers focused on health care coverage, provider knowledge, and access to quality or specialized services
including community counseling services. Health care coverage was the most cited health care barrier. Ten out of sixteen (62%)
of the articles cited financial concerns regarding lack of insurance coverage or out of pocket costs. Provider barriers focused on
lack of referrals (31%), lack of effective referral system to track AAW’s referral progress (6%), lack of knowledge of genetic services
(6%), lack of genetic testing with clinical guidelines for cancer susceptibility (6%), and limited time to counsel (6%). Other health
care concerns included lack of access to quality or specialized services (6%) and limited number of community counseling services
(6%).
Education
Lack of knowledge was the most cited health literacy barrier. Eight out of sixteen (50%) of the articles cited lack of knowledge
about perceived risks, genetic testing process/procedures, risk management results, side effects associated with genetic testing,
and having difficulty making health care decisions about genetic testing and selecting treatment options as barriers. Only one
article (6%) cited language as a barrier.
Economic Stability and Neighborhood and Built Environments
Four out of sixteen articles (25%) cited income related to constraints beyond an individual’s ability to pay for services including
work conflict (6%) as a reason for failing to keep medical appointments. Only one (6%) article cited lack of transportation as a
barrier.
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Table 5 Barriers to genetic testing experienced by African American Women
Social
Factors
Description
Determinants of
Health
Economic
Employment,
Constraints beyond individual’s
stability
Income, medical
ability to pay for services
bills, support

Articles (%)
N=16

6

References

4(25%)

Adams et al,29 Hayden et al,33
Jones et al,13 and Ramirez et
al36

Education

Language Health
literacy/ Education
level

Lack of knowledge:
Perceived risk, testing process,
procedures; risk-management,
results; decision making; side
effects associated with testing

8(50%)

Jones et al,11 Adams et al,29
Sheppard et al,17 Glenn et al,31
Klitzman34, Susswein et al,24
MacNew et al,35 and Sherman
et al38

Social &
community
context

Social integration
Support systems

Discrimination: employment,
healthcare system, preexisting
condition, race

5(31%)

Adams et al,29 Sheppard et
al,17 Glenn et al,31 Susswein et
al,24 and Sheppard et al37

Stigmatization due to breast
cancer status

5(31%)

Ford et al,30 Sheppard et al,17
Sussner et al,39 Sussner et al,40
and Sherman et al38

Sociocultural

Family concerns: Ineffective
communication, lack of
awareness of family history,
medical condition and hereditary
effects, medical

8(50%)

5(31%)

Medical mistrust
3(18%)
Privacy concerns
7(43%)
Cancer fear/worry

Health care
system

Provider access
Linguistic and
cultural
competency

Health care
coverage

Providers: Lack of genetic
knowledge /services and clinical
guidelines for testing and
referrals, ineffective referral
system, limited counseling
Cost, lack of insurance coverage,
or out of pocket costs, inability to
qualify for hardship assistance

Barriers identified in 18% or more studies
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Jones et al,13, Sheppard et al,17
Glenn et al,31 Susswein et al,24
Sherman et al,38 Sussner et
al,39 Sussner et al,40 and
Ramirez et al36
Adams et al,29 Sheppard et
al,17 Glenn et al,31 Sheppard et
al,37 and Sussner et.al40
Sussner et al,39 S Sussner et
al,40 and Sherman et al38
Adams et al,29 Sheppard et
al,17 Ford et al,30 Halbert et al,32
Sussner et al,40 , Sherman et
al,38 and MacNew et al.35

6(37%)

Jones et al,13 Klitzman,34
Sheppard et al,37 Sheppard et
al,17 and Susswein et al24

10(62%)

Jones et al,11 Adams et al,29
Jones et al,13 Sheppard et al,17
Glenn et al,31 Ford et al,30
Susswein et al,24 Sherman et
al,38 Ramirez et al,36 and
Hayden et al33
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DISCUSSION
Evidence from the review suggests the SDOH collectively, influences genetic follow up and how healthcare decision are made
among AAW. Social contexts and community engagement, the healthcare system, and health literacy are identified as key
problematic areas and warrant consideration.
Social and Community Context
Social and community context factors have the greatest influence on AAW’s genetic testing follow up and how they make decisions.
Family concerns have the greatest influence followed by fear/worry about cancer, discrimination related to employment, the
healthcare system or healthcare coverage due to breast cancer status, medical mistrust, and stigmatization respectively. Family
concerns were related to AAW’s inability to discuss their breast cancer conditions because they do not fully understand their breast
cancer conditions and how it impact their families. The main concerns are ineffective communication, lack of awareness of family
history, effects of medical condition, and heredity.
The few published studies exploring medical mistrust demonstrated significant associations with perceived advantages and
disadvantages of genetic testing, as well as medical mistrust among African Americans. The findings revealed how social and
cultural beliefs foster AAW’s misunderstandings about genetic testing elicit medical mistrust, an important predictor of health
behaviors in AAW. The most common reasons for medical mistrust are fear that medical institutions would use genetic test results
exclusively for beneficial reasons, privacy concerns, and loss of medical coverage or employment if their breast cancer status is
identified. These beliefs are closely associated with employment, the healthcare system, or healthcare coverage discrimination.
The misunderstandings highlight the need to dispel myths about breast cancer genetic testing.
Spiritual/religious Beliefs
Several studies (25%) explored AAW’s spiritual/religious cultural beliefs to some degree. Overall, AAW’s attitudes about breast
cancer and genetic testing, are associated with their spiritual/religious beliefs. One study suggests the use of spiritual coping has
been associated with a perception of lower breast cancer risk.21 More work is needed in this area to fully understand
spirituality/religious effects.
Community Engagement
Approaches to address breast cancer health inequality should be addressed at both the individual and community levels. A
Community Partnership Program with local organizations to work in medically African American communities may promote targeted
breast cancer prevention strategies, increase breast cancer genetic testing awareness, and reduce outcome disparities.
Furthermore, the partnership may provide increased sponsorship and support to apply tailored strategies and resources to increase
African Americans’ community engagement.
The Healthcare System
In the healthcare system, insurance coverage and out of pocket costs continue to be primary barriers to genetic testing, followed
by lack of provider genetic knowledge for AAW at risk for breast cancer and ineffective referral tracking systems. The existing data
suggests the cost concerns expressed by the AAW are associated with their socioeconomic status. African Americans have the
lowest median household income among White, Asian and Latino households in the U.S.22 Although the median household income
rose to $57,617 in 2016, for African Americans, it was $38,555, the lowest of all racial groups.22 Moreover, 22% of African American
households live in poverty, and African Americans’ unemployment rate almost doubles the rate of Whites.22 One study showed
affordability and insurance coverage as key reasons for non-genetic test follow up.23
Seeking additional funding opportunities such as community partnership may mitigate costs. Currently, public policies such as the
Affordable Care Act, provide access to healthcare services for genetic screening and preventative services for high risk women.
Community partnerships with health insurance agencies and health care organizations to lower health care costs may increase
AAW’s access to genetic screening and treatment. Nonetheless, factors influencing AAW’s access to care should continue to be
examined to discover the association between cost and other sociocultural factors. One study showed that African Americans
were less likely than Whites to pursue BRCA1/2 genetic testing, even when barriers of cost and access were minimized.24
Referral System
Some high risk AAW who are eligible for genetic testing are not referred; this contributed to a paucity of provider referrals and
inadequate referral tracking systems to track the progression from initial identification and referral for genetic counseling/testing to
genetic specialists and oncologists. One study revealed 5 of 11 women with a history of bilateral breast cancer and carry a BRCA1⁄
2 mutation were not referred for risk assessment at the time of diagnosis, and could have been recommended to reduce the risk
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of developing a second breast cancer.25 More efforts are needed to address this issue because AAW are predisposed to a more
aggressive form of breast cancer at an earlier age than the general population.
Provider Training
African American women have high trust in their personal providers and their recommendations for genetic testing. Other studies
produced similar findings.26,27 Yet, existing evidence suggests providers may not be culturally competent enough to address AAW’s
psychosocial needs, including the need for genetic and specialized services. Cultural competency is key to comprehending how
AAW’s attitudes and beliefs, impact their health, and consequently, improve patient-provider relations. The majority of genetic
services providers (91%) and counselors in the U.S., are White, from a different ethnic group and may not understand AAW’s
needs.25
One study surveyed 220 internists about their genetic utilizations; findings showed most rated their knowledge as very/somewhat
poor concerning geneticists/genetic counselors, types of tests to order, counseling patients, interpreting results and maintaining
privacy.28 Providers may not know how to identify and treat high risk patients or make appropriate referrals. Several studies suggest
physicians with poorer understanding of breast cancer genetics recommend genetic services less frequently.25 Increasing culturally
competent, knowledgeable providers may improve patient-provider relationships, build trust and provide AAW with the information
to make informed, valued decisions.
Health Literacy/Education
Fifty percent of the studies identified culturally tailored education for AAW and their families as key to increasing genetic breast
cancer awareness and early detection, mitigating misconceptions about genetic testing, improving informed valued decisions about
genetic testing and treatment options, and improving clinical outcomes. Recurring themes focused on helping AAW understand
the advantages and disadvantages to genetic testing, how to make use of the genetic test results for themselves and their families,
how breast cancer impacts their health behaviors and lifestyle choices, and how to reduce their risk of dying from breast cancer.
Furthermore, evidence suggests that forums to discuss the roles of spiritual and religious values, beliefs and attitudes, and family
or friends influence on the decision-making process may improve the accuracy of their risk perceptions.
RECOMMENDATIONS
The existing evidence suggests a multi-faceted approach should be taken to address the multidimensional nature of breast cancer
disparity among AAW. Their families are key motivators to genetic follow up and should be included. Furthermore, AAW make
decisions based on family values, and genetic follow up is associated with understanding more about their families’ breast cancer
risk. A comprehensive, tailored genetic breast cancer education and outreach screening intervention is needed, as African
Americans and other minorities trail behind in the utilization of genetic services to reduce breast cancer mortality rates, improve
survival rates, and health and quality of life. Table 6 summarizes the recommendations. Three major categories of
recommendations in the reviewed studies are relevant to addressing barriers to genetic follow up and treatment. These categories
are associated with the SDOH and include biologic and psychosocial topics related to health literacy, social and community context,
and the healthcare system. They should be considered when developing tailored breast cancer risk program content for AAW.
LIMITATIONS
This review has several limitations. The review explores barriers and why AAW do not progress to genetic testing. As a result,
most of the studies are descriptive and cross-sectional in nature and do not allow for determination of cause and effect relationships
in the observed associations. Other limitations include self-reported data regarding the use of genetic services, some samples are
not reflective of AAW with less education or low income, some studies have small sample sizes, some underrepresent younger
AAW, and others are limited to those published in the U.S. Furthermore, there is limited experimental data on why AAW do not
progress to genetic testing, and some results are not generalizable to other populations. Despite these limitations, the results are
meaningful. Studies included a diverse set of AAW from different regions of the U.S. but still produced similar findings.
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Table 6. Recommendations for Designing Tailored Breast Cancer Risk Programs for African American Women (AAW)
Category
Description
Education
Rationale: Improve patient-provider relationship. Develop culturally competent providers and increase their
genetic utilization and increase African American women’s breast cancer genetic
awareness.11,13,23,27, 29-31,36,39
Primary care provider training
Cultural competency (include unique cultural beliefs of minorities)
Exploration of unconscious biases
Identification of breast cancer support services and how to refer
Utilization of breast cancer genetic testing clinical guidelines, include ordering and interpreting genetic
results and genetic privacy
Utilization of a standardized risk assessment tool

Healthcare
System

African American women and family education
Breast cancer awareness
Family history
Breast cancer genetics: counseling/testing: process/procedure, benefits, advantages and
disadvantages, risks, reliability of test results
Medication side effects
Psychosocial exploration: trust related to data usage, breast cancer worry/fear
Stigmatization and perceptions
Cultural exploration of spiritual and religious values, decision-making with decision-making aids
Genetic Information Nondiscrimination Act law to dissipate fear of discrimination.
Rationale: Improve access to quality or specialized services to increase early detection, diagnosis and
treatment.11,13,17,23,24,29-31,33,36,38
Establish an effective referral tracking system to track progress:
Utilization of electronic record system
Standardized family history data collection forms to identify high risk individuals
Available genetic services within settings that provide healthcare services to large
numbers of AAW
Risk assessment
Conduct breast cancer risk assessment screening during annual,/primary care or
gynecologic visits
Target younger AAW at increased risk for breast cancer

Social &
Community
Context

Explore opportunities to increase health care coverage and reimbursement
Rationale: Promote community engagement to increase access to effective care and treatment. 24,29,37,38
Establish community level breast cancer education and risk assessment
Support outreach efforts to groups that provide information and support to younger breast cancer victims
Identify places within the communities with flexible counseling hours
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IMPLICATIONS FOR PRACTICE AND/OR POLICY
These findings have decisive implications for medical practice, education, community leaders, and policy makers. Although AAW
who are at increased risk may report positive interests about genetic testing, few elect to follow-up with genetic testing. The limited
number of studies that have evaluated genetic test acceptance in this population, suggest that barriers to participation in genetic
counseling/testing, continues to exist. Furthermore, few interventions have been designed to fully address the multifaceted nature
of AAW who are at high risk for breast cancer nor developed comprehensive interventions that address the influence of multiple
SDOH that present as barriers for many minority women. Many of the barriers that are addressed in this review are the unresolved
barriers that existed over 15 years ago, indicating the need to develop educational interventions as adjuncts to genetic
screening/testing and increase access to effective care and community engagement.
The results of this review could be used to design comprehensive, tailored interventions to address the identified barriers, increase
breast cancer awareness and early detection, and help minority women make informed, value decisions about genetic testing and
treatment options. Given the breast cancer impact on women, as well as nationally and premature deaths rates, efforts should
continue to increase access to effective care and treatment, especially in underserved communities.
Future studies are needed to examine methods to increase community engagement and its impact on breast cancer awareness
and decreasing the mortality rate; assess provider education for those who do not specialize in breast cancer; examine how race
and cultural identity influence beliefs about genetic testing, explore emotional and psychosocial factors related to genetic follow
up, and identify factors influencing the decision-making process. We recommend using larger sample sizes reflective of a diverse
African American population and include more AAW who are younger and at high risk, have low income and education level, and
are uninsured/underinsured.
CONCLUSIONS
This systematic review is one of the few reviews to synthesize current published literature focused on the social determinants of
health (SDOH) factors collectively, influencing breast cancer genetic follow up from the perspective of AAW who are at risk for
breast cancer, to determine why they do not progress to genetic testing. It provides greater understanding of how SDOH, especially
cultural beliefs and attitudes about breast cancer, influence decisions about genetic testing and treatment. Furthermore, the review
includes recommendations for designing tailored breast cancer risk programs for AAW to reduce breast cancer disparity. The
review highlights the need to accurately assess AAW’s perceptions about breast cancer and their progression to genetic services.
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Appendix A
Table 4. Study Characteristics and Summary of Key Findings of Factors Influencing Genetic Uptake (Appendix A, 1/3)
Author,
Year
Adams
et al29

Design

Sample
Size
N = 50

Sample Population
(U.S. region, age)
East, AAW, ≥21

Focus

Measures

Crosssectional

Assessed
knowledge and
perception of GC for
BRCA1/2

Knowledge,
motivator, barrier
and interest

Ford et
al30

Focus
groups

N = 20

Midwest, AAW, WW

Explored
knowledge,
attitudes and
cultural beliefs of
breast cancer

Glenn et
al 31

Semistructural
interviews

N = 33

Assessed GC/GT
awareness and
factors influencing
GT follow-up

Halbert
et al32

Randomized
trial,
longitudinal

N = 176

West, White, Asian,
Latino and African
American survivors or
first-degree relatives of
survivors, mean age
52
East, AAW, adults

Sociodemographics,
cognitive
/psychological,
social support and
programmatic
factors
Factors influencing
genetic follow-up

Hayden
et al33

Prospective
analysis,
longitudinal

N=
10,726

Midwest, Asian,
African American and
White adults

Analyzed reasons
GT not pursue after
GC

Evaluated the
effects of GC/GT
based on different
levels of exposure

Evaluated cancer
perceived risk and
cancer worry

Sociodemographic, GT
patterns and
barriers to GT
Key: AAW, African American Women; WW, White Women; GC, Genetic counseling; GT, Genetic testing
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Key Findings

Grade
Quality
3

Recommended
Grade
A

3

B
Unclear
management
strategy

Low levels of awareness observed in
minority women, beliefs influenced
decisions about treatment options,
mistrust of genetic information.

3

A

Counseling participants reported
perceived risk compared to nonparticipants, test result acceptors
reported decreases in cancer worry,
having a cancer history associated
with increases in cancer worry
51.4% did not pursue GT following
GC-not indicated, 22.5%-cost
concerns, 17.1%-disinterest

2

A

3

A

88% never heard of BRCA1/2, 54%
aware of GT, 94% GT interest
Motivators: physician
recommendation, health awareness
and family history
All groups associated “breast cancer”
with fear;
AAW who did not receive GC were
most knowledgeable; WW who did not
receive GC; reported uncertainty and
mistrust about GC/GT
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Table 4. Study characteristics and key findings of factors influencing genetic uptake (Appendix A, 2/3)
Author,
Year
Jones et
al11

Design

Sample
Size
N = 23

Sample Population
(U.S. region, age)
General population of
AAW at increased
risk, < 50

Descriptive
critical review

Jones et
al13

Examined factors
influencing
screening

factors influencing
need for health
services

Prospective
RCT

N = 340

Midwest, AA
survivors,
age 20-45

Examined factors
associated with
GC/GT

Knowledge/attitude,
subjective norms,
family support and
perceived control

Klitzman34

Semistructured
interview

N = 32

AAs, Whites, Asians,
Hispanics with breast
cancer, age 20-69

Explored
misunderstandings
about GT

Factors influencing
GT

MacNew et
al35

Descriptive
survey

N = 222

Southeast, AA, White
and Hispanic women,
adults

Assessed sociodemographics, GT
awareness

Socio-demographics,
knowledge and
attitude

Ramirez et
al 36

Crosssectional

N = 49

Evaluated ethnic
differences in
breast cancer
knowledge, belief
and GT follow-up

Socio-demographics,
knowledge, attitude,
self-efficacy and
cultural
characteristics

Sheppard
et al37

Crosssectional

N = 100

General population
AA, White,
Appalachian, Native
American, Asian
American, women,
age 25-49
Mid-Atlantic AAW at
increased risk for
carrying BRCA1/2

Examined
sociocultural
factors associated
with medical
mistrust and
genetic
discrimination

Socio-demographics,
mistrust, self-efficacy,
discrimination and
engagement
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Focus

Measures

Key Findings
Younger AAW are not referred for
GT when appropriate and
make decisions based on family
values
Significantly, less AAW-reported
having GC and GT
compared with WW/others,
Income associated positively with
GC/GT
Higher education levels
negatively associated with GC
Most common-lack of
understanding about GT

Women with advanced degrees
are most informed about BRCA
GT, More WW knew about breast
cancer genetics than other groups
High GT interest
Significant cultural differences
associated with benefit and risk,
providers’ recommendations,
medical mistrust, family effects,
and cost
Reported interest in GC/GT does
not translate into actual GC/GT
engagement
43% were not referred for GC/GT

Grade
Quality
3

Recommended
Grade
A

3

A

3

4

B groups’ data
are not
partitioned
according to
condition
A

4

A

4

A
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Table 4. Study characteristics and key findings of factors influencing genetic uptake (Appendix A, 3/3)
Author,
Year
Sheppard
et al17

Design
Semistructured
interviews

Sample
Size
N = 21

Sample Population
(U.S. region, age)
East, AA adults at
risk for hereditary
breast cancer

Focus

Measures

Explored barriers and
motivators to genetic
follow-up

Knowledge,
beliefs and
attitudes about
GC/GT

Sherman
et al38

Systematic
Review

N = 18

General population
of AAW who
participated in
GC/GT

Reviews included factors
influencing GT follow-up
and decision making.

Knowledge,
perceived risk,
beliefs, and
emotional factors
influencing
GC/GT uptake

Sussner
et al39

Crosssectional

N = 146

Examines the relationship
of acculturation and breast
cancer distress with
perceived barriers to GT

Acculturation
predictors, breast
cancer specific
distress

Sussner
et al40

Crosssectional

N = 160

Explored ethnic, racial,
and cultural identity
factors associated with GT
follow-up

Ethnic, racial, and
cultural identity
predictors

Susswein
et al24

Retrospective
longitudinal

N = 768

East, AA adults at
increased risk of
hereditary breast
and/or ovarian
cancer
East, AA,
Black-West Indian/
Caribbean and
Black-Other women
at increased risk for
hereditary breastovarian cancer
South, AAW and
WW who received
GC

Assessed BRCA1/2 GT
uptake in recent
diagnosed and ≥1 year
later

Genetic uptake
by date
diagnosed and
race
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Key Findings
Low knowledge level about GC
and BRCA1/2, spiritual beliefs
were described as a potential
source of hope and coping,
Motivators: help family members,
insurance coverage, and benefit
community
AAW reported interest in GC/GT
does not translate into actual
GC/GT engagement, low GT
knowledge level,
spirituality associated with
increased uptake, pretest
counseling reduced cancer worry
and greater decision satisfaction,
GC that incorporates beliefs,
reported less worries
Foreign born associated with
negative emotional reactions about
GT, breast cancer distress scores
were positively associated with
negative emotional reactions
Strong sense of ethnic identity
related to having more positive
beliefs and attitudes about GT,
high ethnic search and racial
identity scores associated with
decrease uptake of GC/GT
More WW pursued GT than AAW,
AAW recently diagnosed had a
higher odd of progressing to GT
than longer survivors

Grade
Quality
4

Recommended
Grade
A

1

A

3

A

4

A

4

A

